Hilton Head Capital Partners »

Biodexa Pharmaceuticals shares owned by Hilton Head Capital Partners

Quarter-by-quarter ownership of Biodexa Pharmaceuticals (BDRX) shares owned by Hilton Head Capital Partners from 13F filings

Historical chart of Hilton Head Capital Partners investment in Biodexa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biodexa Pharmaceuticals held by Hilton Head Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biodexa Pharmaceuticals by Hilton Head Capital Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $18 30 0.63

More positions owned by Hilton Head Capital Partners

First Trust Etf Iv First Trust Enhanced Short First Tr Enh New (FTSM)
Ft Vest S&p 500 Dividend Aristocrats Target Income Etf Ft Vest S&p 500 (KNG)
Ft Vest Laddered Buffer Etf Ft Vest Laddered (BUFR)
Schwab Us Dividend Equity Etf Us Dividend Eq (SCHD)
Eli Lilly & Co. (LLY)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
First Trust Capital Strength Etf Cap Strength Etf (FTCS)
Philip Morris International (PM)
Wal-Mart Stores (WMT)
First Trust Nasdaq Rising Dividend Achievers Risng Divd Achiv (RDVY)
Johnson & Johnson (JNJ)
Lam Research Corporation Com New (LRCX)

View all positions for Hilton Head Capital Partners

Top funds holding Biodexa Pharmaceuticals

Sabby Management
Armistice Capital
GAMMA Investing
UBS Group
Hilton Head Capital Partners
Rhumbline Advisers
Caitong International Asset Management

View all funds holding Biodexa Pharmaceuticals